Cover of: The official patient Read Online
Share

The official patient"s sourcebook on opsoclonus myoclonus

  • 281 Want to read
  • ·
  • 58 Currently reading

Published by Icon Health Publications in San Diego, Calif .
Written in English

Subjects:

  • Bibliography,
  • Diseases,
  • MEDICAL,
  • Neurology,
  • Myoclonus,
  • HEALTH & FITNESS,
  • Popular works,
  • Nervous System (incl. Brain)

Book details:

Edition Notes

StatementJames N. Parker and Philip M. Parker, editors
ContributionsIcon Group International, Inc
Classifications
LC ClassificationsRC378 .O34 2002eb
The Physical Object
Format[electronic resource] /
Pagination1 online resource (ix, 90 p.)
Number of Pages90
ID Numbers
Open LibraryOL27078452M
ISBN 100585446245
ISBN 109780585446240
OCLC/WorldCa52229654

Download The official patient"s sourcebook on opsoclonus myoclonus

PDF EPUB FB2 MOBI RTF

  Opsoclonus-myoclonus syndrome (OMS) is a rare disorder that affects the nervous system. Symptoms include rapid, multi-directional eye movements (opsoclonus), quick, involuntary muscle jerks (myoclonus), uncoordinated movement (ataxia), irritability, and sleep disturbance. Bartos A. Effective high-dose clonazepam treatment in two patients with opsoclonus and myoclonus: GABAergic hypothesis. Eur Neurol ; Fernandes TD, Bazan R, Betting LE, da Rocha FC. Topiramate effect in opsoclonus-myoclonus-ataxia syndrome. Arch Neurol ; An association between neuroblastoma and opsoclonus-myoclonus syndrome (OMS) was described as early as within the first report on the transformation of malignant neuroblastoma to a benign ganglioneuroma. It was not recognized at that time nor was it appreciated in the subsequent follow-up report on the same patient in Cited by: Ofatumumab for refractory opsoclonus-myoclonus syndrome following neuroblastoma. Pediatr Blood Cancer ;E Battaglia T, De Grandis E, Mirabelli-Badenier M, Boeri L, Morcaldi G, Barabino P, et al. Response to rituximab in 3 children with opsoclonus-myoclonus syndrome resistant to conventional treatments. Eur J Paediatr Neurol ;

Opsoclonus-Myoclonus Syndrome in Patients With Locked-in Syndrome: A Therapeutic Porthole With Gabapentin Francesca Pistoia, Massimiliano Conson, Marco . Opsoclonus myoclonus syndrome (OMS), also known as opsoclonus-myoclonus-ataxia (OMA), is a rare neurological disorder of unknown cause which appears to be the result of an autoimmune process involving the nervous is an extremely rare condition, affecting as few as 1 in 10,, people per year. It affects 2 to 3% of children with neuroblastoma and has been reported to occur with Specialty: Neurology. Synonyms: Opsoclonus myoclonus syndrome, OMS, Kinsbourne syndrome, Ataxo-opso-myoclonus syndrome, OMA syndrome, Opsoclonus-myoclonus-ataxia syndrome, Dancing eye-dancing feet syndrome, Dancing eye syndrome, POMA syndrome, Paraneoplastic opsoclonus-myoclonus, Paraneoplastic opsoclonus-myoclonus-ataxia syndrome. ClinicalNeuropharmacology Vol. 19, No. 1, pp. CLippincott-Raven Publishers, Philadelphia Review TheImmunopharmacology ofthe Opsoclonus-Myoclonus Syndrome MichaelR. Pranzatelli DepartmentsofPediatrics, Neurology, andPharmacology, The George Washington.

Opsoclonus-myoclonus symptoms may sometimes occur in patients with brainstem lesions, together with palatal tremor, orofacial stereotypes, and abnormal posturing movements. 7 As a consequence of the brainstem lesion, patients with locked-in syndrome may occasionally show opsoclonus-myoclonus symptoms that further contribute to their disability Cited by:   지민 & RM 경쾌한 캐럴 ‘Santa Claus Is Coming To Town’ | SBS 가요대전( SBS K-POP AWARDS) | SBS Enter. - Duration:   Presleigh Voelker Opsoclonus Myoclonus syndrome. The best sleeping position for back pain, neck pain, and sciatica - Tips from a physical therapist - Duration: Tone and Tighten Recommended. Opsoclonus-myoclonus ataxia syndrome (OMS) is a rare immune mediated paraneoplastic syndrome that occurs in approximately 2 to 3% of children with neuroblastoma. Children with neuroblastoma associated opsoclonus-myoclonus tend to have a favorable prognosis from the .